{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:48Z","timestamp":1786985088396,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.beem.2024.101894","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T12:30:17Z","timestamp":1712061017000},"page":"101894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives"],"prefix":"10.1016","volume":"38","author":[{"given":"Federica","family":"Guaraldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Di Sciascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Asioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.beem.2024.101894_bib1","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2024.101894_bib2","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Endocrine Society. Acromegaly: an Endocrine Society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101894_bib3","series-title":"Endocrine and Neuroendocrine Tumours. WHO Classification of Tumours Series","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12022-015-9361-z","article-title":"Treatment of invasive silent somatotroph pituitary adenoma with temozolomide. Report of a case and review of the literature","volume":"26","author":"Ghazi","year":"2015","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","article-title":"The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas","volume":"26","author":"Nishioka","year":"2015","journal-title":"Endocr Pathol"},{"issue":"10","key":"10.1016\/j.beem.2024.101894_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.1016\/j.beem.2024.101894_bib7","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/jcm10112254","article-title":"An update on pituitary neuroendocrine tumors leading to acromegaly and Gigantism","volume":"10","author":"Asa","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1530\/ERC-14-0305","article-title":"Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences","volume":"22","author":"Potorac","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.beem.2024.101894_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1507\/endocrj.EJ11-0177","article-title":"Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas","volume":"59","author":"Kato","year":"2012","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-12-0864","article-title":"Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas","volume":"168","author":"Larkin","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2024.101894_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.beem.2009.05.010","article-title":"Pituitary tumours: acromegaly","volume":"23","author":"Chanson","year":"2009","journal-title":"Best Pr Res Clin Endo- crinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2024.101894_bib12","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2024.101894_bib13","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Endocrine Society. Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2024.101894_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2024.101894_bib15","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101894_bib16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classifcation framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) Expert Consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2024.101894_bib17","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa205","article-title":"Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time?","author":"Ho","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2024.101894_bib18","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.21037\/tcr-20-3446","article-title":"Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.beem.2024.101894_bib19","series-title":"Central nervous system tumours. WHO classification of tumours series","author":"WHO Classification of Tumours Editorial Board","year":"2021"},{"issue":"fasc. 6","key":"10.1016\/j.beem.2024.101894_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","article-title":"A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal","volume":"vol. 475","author":"Villa","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2024.101894_bib21","unstructured":"WHO International Classification of Diseases 11th Revision. Available from: \u3008https:\/\/icd.who.int\/en\u3009."},{"key":"10.1016\/j.beem.2024.101894_bib22","first-page":"593","volume":"187","author":"Burman","year":"2022","journal-title":"ESE Surv Collab Aggress Pituit Tumours Carcinomas, Charact Manag 171 Patients"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib23","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1093\/ejendo\/lvad042","article-title":"Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?\u2014that is the question","volume":"188","author":"Trouillas","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2024.101894_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0032-1331697","article-title":"AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma","volume":"121","author":"Nishizawa","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"10.1016\/j.beem.2024.101894_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/PAS.0000000000000806","article-title":"Mixed gangliocytoma-pituitary adenoma: insights on the pathogenesis of a rare sellar tumor","volume":"41","author":"Lopes","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.beem.2024.101894_bib26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3390\/jcm8101741","article-title":"Hypothalamic endocrine tumors: an update","volume":"8","author":"Asa","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.beem.2024.101894_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","article-title":"Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form","volume":"19","author":"Obari","year":"2008","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1016\/j.beem.2024.101894_bib30","series-title":"Functional Endocrine Pathology","first-page":"245","article-title":"The adenohypophysis","author":"Horvath","year":"1991"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib31","doi-asserted-by":"crossref","DOI":"10.3171\/2010.7.FOCUS10169","article-title":"Growth hormone-secreting adenomas: pathology and cell biology","volume":"29","author":"Lopes","year":"2010","journal-title":"Neurosurg Focus"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2024.101894_bib32","first-page":"4","article-title":"Clinical implications of accurate subtyping of pituitary adenomas: perspectives from the treating physician","volume":"31","author":"Gomez-Hernandez","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.beem.2024.101894_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.humpath.2020.10.004","article-title":"Cytokeratin profiles in pituitary neuroendocrine tumors","volume":"107","author":"Asa","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beem.2024.101894_bib34","first-page":"505","article-title":"Fibrous bodies in growth hormone-secreting adenomas contain cytok- eratin filaments","volume":"109","author":"Neumann","year":"1985","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.beem.2024.101894_bib35","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.beem.2024.101894_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11102-017-0791-0","article-title":"Somatostatin receptor ligands in the treatment of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.beem.2024.101894_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0029-1211342","article-title":"Gangliocytomas of the sellar region--a review","volume":"103","author":"Puchner","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2024.101894_bib44","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2024.101894_bib45","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2024.101894_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00687965","article-title":"Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy","volume":"71","author":"Felix","year":"1986","journal-title":"Acta Neu- ropathol"},{"key":"10.1016\/j.beem.2024.101894_bib47","article-title":"Non-Functioning Pituitary Adenomas","volume":"2000","author":"Drummond","year":"2022"},{"issue":"4","key":"10.1016\/j.beem.2024.101894_bib48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","article-title":"GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors","volume":"32","author":"Mete","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib49","first-page":"75","article-title":"Pituitary adenomas and craniopharyngiomas are CDX2 negative neoplasms","volume":"48","author":"Schittenhelm","year":"2010","journal-title":"Folia Neuropathol"},{"issue":"9","key":"10.1016\/j.beem.2024.101894_bib50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/PAS.0000000000000908","article-title":"Serotonin, ATRX, and DAXX expression in pituitary adenomas: markers in the differential diagnosis of neuroendocrine tumors of the Sellar Region","volume":"41","author":"Casar-Borota","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101894_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00401-024-02686-1","article-title":"Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features","volume":"147","author":"Dottermusch","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.beem.2024.101894_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/ENDO:28:1:115","article-title":"Pituitary carcinoma: diagnosis and treatment","volume":"28","author":"Lopes","year":"2005","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.beem.2024.101894_bib53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"ESE survey collaborators. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12022-019-9568-5","article-title":"An institutional experience of tumor progression to pituitary carcinoma in a 15-year cohort of 1055 consecutive pituitary neuroendocrine tumors","volume":"30","author":"Alshaikh","year":"2019","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101894_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cen.14197","article-title":"A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s","volume":"93","author":"Guaraldi","year":"2020","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2024.101894_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","article-title":"Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody","volume":"38","author":"Thapar","year":"1996","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.beem.2024.101894_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"ESE survey collaborators. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-18-0749","article-title":"Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre","volume":"180","author":"Asioli","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3171\/jns.2002.96.2.0352","article-title":"Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases","volume":"96","author":"Gaffey","year":"2002","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(98)00013-5","article-title":"Loss of Rb expression in an ACTH-secreting pituitary carcinoma","volume":"126","author":"Hinton","year":"1998","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.beem.2024.101894_bib61","doi-asserted-by":"crossref","first-page":"640","DOI":"10.5858\/2010-0470-SAR1.1","article-title":"Protocol for the examination of specimens from patients with primary pituitary tumors","volume":"135","author":"Nos\u00e9","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib62","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/cancers12020514","article-title":"How to classify pituitary neuroendocrine tumors (PitNET) s in 2020","volume":"12","author":"Trouillas","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2024.101894_bib63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","article-title":"A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal","volume":"475","author":"Villa","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2024.101894_bib64","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.21037\/tcr-20-3446","article-title":"Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.beem.2024.101894_bib65","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAT.0b013e32834915e8","article-title":"Surgical pathology reporting at the crossroads: beyond synoptic reporting","volume":"43","author":"Ellis","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.beem.2024.101894_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00428-015-1834-4","article-title":"Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence- based datasets","volume":"468","author":"Ellis","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2024.101894_bib67","unstructured":"Asioli S., Guaraldi F., Zoli M., et al., How to standardize the diagnostic approach to pituitary neuroendocrine tumors (PitNETs); Minerva Endocrinology \u2013 In Press."},{"issue":"3","key":"10.1016\/j.beem.2024.101894_bib68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","article-title":"Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes","volume":"121","author":"Nishioka","year":"2014","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2024.101894_bib69","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JME-12-0113","article-title":"Biomarkers of aggressive pituitary adenomas","volume":"49","author":"Mete","year":"2012","journal-title":"J Mol Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.beem.2024.101894_bib70","first-page":"4","article-title":"Clinical implications of accurate subtyping of pituitary adenomas: perspectives from the treating physician","volume":"31","author":"Gomez-Hernandez","year":"2015","journal-title":"Turk Patoloji Derg"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T18:59:54Z","timestamp":1715108394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1521690X24000484"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101894","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101894"}}